Haff N, Horn DM, Bhatkhande G, Sung M, et al. Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial. Am Heart J 2025 Feb 20:S0002-8703(25)00038-9. doi: 10.1016/j.ahj.2025.
PMID: 39986337